The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study.

Dogan, Izzet; Ayhan, Murat; Gurbuz, Mustafa; Kucukarda, Ahmet; Aydin, Esra; Urun, Yuksel; Cicin, Irfan; Saip, Pinar

Dogan, Izzet; Ayhan, Murat; Gurbuz, Mustafa; Kucukarda, Ahmet; Aydin, Esra; Urun, Yuksel; Cicin, Irfan; Saip, Pinar.

Affiliation

Dogan I; Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.
Ayhan M; Department of Medical Oncology, Dr. Lutfi Kirdar Kartal City Hospital, Istanbul, Turkey.
Gurbuz M; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
Kucukarda A; Department of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Aydin E; Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.
Urun Y; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
Cicin I; Department of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Saip P; Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.

Medicine (Baltimore) ; 101(35): e30147, 2022 Sep 02.

Article de En | MEDLINE | ID: mdl-36107512

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Système ABO de groupes sanguins / Tumeur du sein de l'homme Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male Langue: En Journal: Medicine (Baltimore) Année: 2022 Type de document: Article Pays d'affiliation: Turquie Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google